Description:

AMC-061 Study Drug Administration Form (DA1) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6DBDC738-4455-D324-E040-BB89AD433B23

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6DBDC738-4455-D324-E040-BB89AD433B23

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00890747 Treatment - AMC-061 Study Drug Administration Form (DA1) - 2913633v1.0

No Instruction available.

  1. StudyEvent: AMC-061 Study Drug Administration Form (DA1)
    1. No Instruction available.
Header Module
Enter Total Dose Of Study Drug Received This Cycle And Dose Modification Codes
Agent Dose Level
Dose Modification
Comments